Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
6 Novice Cameras for 2024: Ideal for New Picture takers - 2Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
- 3Blue Origin safely launches wheelchair user to space and back
- 4Somaliland denies trading recognition with Israel for accepting Gazans
- 5Building Tough Connections: Individual Bits of knowledge on Association
- Mating injuries may lead scientists to identify dinosaurs’ sex
- 21 Things You Ought to Never Share with Your Childless Companion
- Monetary Security: Building Serious areas of strength for an Establishment
- Judge sets $60K bond for Florida congresswoman accused of stealing $5M in COVID-19 funds
- The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
- Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- 6 Solid Moving Administrations for a Calm Movement
- Canada cancels its 1st moon rover: 'It's hopefully not a lost cause'
- Does physics say that free will doesn't exist?
